US2012010215A1PendingUtilityA1

Treatment of bacterial diseases of the respiratory organs

Assignee: ENDERMANN RAINERPriority: Feb 10, 2003Filed: Jul 28, 2011Published: Jan 12, 2012

Est. expiryFeb 10, 2023(expired)· nominal 20-yr term from priority

Inventors:Rainer Endermann Harald Labischinski Christoph H. Ladel Uwe Petersen Ben Newton

A61P 31/00A61P 31/04A61P 11/08A61P 11/00A61K 9/0075A61K 31/496

PatentIndex Score

Cited by

References

Claims

Abstract

The invention relates to inhalable quinolonecarboxylic acid derivative compositions for local control of diseases of the respiratory organs, in particular of lung diseases.

Claims

exact text as granted — not AI-modified

1 - 8 . (canceled) 
     
     
         9 . A method of treating a bacterial disease of the lungs in a human or animal comprising the step of locally administering an antibacterially effective amount of a solid ciprofloxacin betaine in a powder form or powder-containing suspension. 
     
     
         10 . The method according to claim  1 , wherein the bacterial disease of the lungs is associated with cyctic fibrosis, chronic obstructive pulmonary diseases (COPD), or bronchiactasis.

Join the waitlist — get patent alerts

Track US2012010215A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.